Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA StudyYasunori Murata, Nobuhiko Seki, Eisaku Miyauchi et al.|JTO Clinical and Research Reports|2023Cited by 5
TRUST-II: A global phase II study for taletrectinib in <i>ROS1</i> fusion–positive lung cancer and other solid tumors.Misako Nagasaka, Yuichiro Ohe, Shunichi Sugawara et al.|Journal of Clinical Oncology|2022Cited by 4